stockrowChina Pharma Holdings, Inc. (CPHI) vs InterCure Ltd. (INCR)
- China Pharma Holdings, Inc. CPHI 0.57 +7.55%
- InterCure Ltd. INCR 3.25 −1.52%
China Pharma Holdings, Inc. and InterCure Ltd. are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. is the larger, with a market value of $39.1M against $22.8M — 1.7× the size. China Pharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 6.2×. InterCure Ltd. grew revenue faster over the last twelve months: 16.2% against −11.0%. InterCure Ltd. has the higher net margin (4.88% vs −114.3%) and the higher return on invested capital (0.00% vs −7.23%). Across the 18 metrics below, InterCure Ltd. leads on 15 and China Pharma Holdings, Inc. on 3.
Valuation
Profitability
| Metric | CPHI | INCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 11.76% | 32.74% | 53.51% |
| Operating margin | (111.84%) | 0.00% | 0.00% |
| Net margin | (114.33%) | 4.88% | (2.45%) |
| Free cash flow margin | (3.59%) | 0.00% | 0.00% |
| Return on equity | (20.99%) | 0.00% | (0.80%) |
| Return on assets | (15.30%) | 0.00% | (1.67%) |
| Return on invested capital | (7.23%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack